SCOTTSDALE, Ariz.--(BUSINESS WIRE)--April 5, 2006--Dr. Morgan, president and chief executive officer of InNexus Biotechnology Inc. (TSX: IXS - News; OTCBB: IXSBF - News), an innovative antibody-driven drug development company based on SuperAntibody(TM) Technologies, will be presenting at the BIO 2006 Annual International Convention Business Forum. The presentation will take place on Wednesday, April 12 at 12 p.m. in Room A of McCormick Place South Convention Center, Level 3, Exhibit Hall A.
